ATHA NASDAQ
Athira Pharma, Inc.
1W: +0.8%
1M: +78.1%
3M: +80.2%
1Y: +37.6%
3Y: -75.4%
5Y: -97.8%
$6.75
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$101M
+19.6% ▲
Net Income
-$97M
+17.6% ▲
EPS (Diluted)
$-25.20
+18.4% ▲
EBITDA
-$96M
+23.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2M | $479K | $0 | $0 | $0 |
| Gross Profit | -$2M | -$479K | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $13M | $43M | $61M | $94M | $71M |
| SG&A Expenses | $7M | $21M | $33M | $33M | $26M |
| Operating Expenses | $18M | $64M | $104M | $125M | $101M |
| Operating Income | -$20M | -$64M | -$104M | -$125M | -$101M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $367K | $3K | $24M | $0 | $0 |
| Income Before Tax | -$20M | -$55M | -$96M | -$118M | -$97M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20M | -$55M | -$96M | -$118M | -$97M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-6.10 | $-14.90 | $-25.30 | $-30.90 | $-25.20 |
| EBITDA | -$20M | -$54M | -$88M | -$126M | -$96M |
| Shares Outstanding | 3M | 4M | 4M | 4M | 4M |